Privacy·Terms·Disclaimer

Bibliographic data courtesy of the U.S. National Library of Medicine (NLM), sourced from PubMed/MEDLINE.

SciRadar is not affiliated with, endorsed by, or sponsored by NLM or NCBI. Abstracts remain © their respective publishers.

CONTACT-02: limited clinical benefit and a suboptimal control group - Authors' reply. — SciRadar

Back to results

The Lancet. Oncology

CONTACT-02: limited clinical benefit and a suboptimal control group - Authors' reply.

Neeraj Agarwal, Axel S Merseburger, Svetlana Andrianova, Arun A Azad

Published: 202510.1016/S1470-2045(25)00538-8

No abstract available for this study.